Advertisement
Screener

Tango Therapeutics, Inc. (TNGX) Deferred Tax Assets, Operating Loss Carryforwards

2.4 / 5 stars · 26/54 Roast Me

Tango Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards

Tango Therapeutics, Inc. (TNGX) had Deferred Tax Assets, Operating Loss Carryforwards of $78.50 million as of 2025-12-31, per its 10-K filed 2026-03-05.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-05

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $78.50M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $30.64M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.58M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $7.60M.
Period endDeferred Tax Assets, Operating Loss CarryforwardsDeferred Tax Assets, Operating Loss Carryforwards as first filed
2025-12-31$78.50M
10-K · filed 2026-03-05
2024-12-31$30.64M
10-K · filed 2026-03-05
2023-12-31$16.58M
10-K · filed 2025-02-27
2022-12-31$7.60M
10-K · filed 2024-03-18
2021-12-31$4.40M
10-K · filed 2023-03-27
2020-12-31$11.09M
10-K · filed 2022-03-28
$31.36K
10-K · filed 2021-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Veradermics, Inc (MANE)United States$4.839B
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15